Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-8.34 %
$ 70.1 M
Market Cap
0.07
P/E
AVTX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities AVTX - Avalo Therapeutics, Inc.
25 M
LAST VALUE
-51.57%
2 YEAR CAGR
19.21%
5 YEAR CAGR
16.55%
10 YEAR CAGR